Organizer of Annual IvaDean Concert Reflects on Event
The ninth annual IvaDean Medical Student Scholarship Benefit Concert was held Dec. 7 in Kresge Auditorium to support the IvaDean Medical Student Scholarship Fund.
This year's event raised more than $3,500, a 3.4 % increase over last year's concert.
Fourth-year medical student and concert organizer Khanh Cao talks below about what went into planning this years event and explains why the concerta favorite among faculty, staff and studentsmeans so much to the College of Medicine and the Academic Health Center.
What is involved in organizing the concert?
"You have to be able to plan four to five months ahead. My greatest concern was the need for so much sound equipment, and in previous years, it was supplied by a medical student. But then I met Bernie Wells of the UC Foundation and (College of Medicine graduate) Dr. (Albert) Weisbrot, who lent it all to us. That was the No. 1 concern because without sound, theres no concert. Even though I ran the show, there are committees, and it couldnt be couldnt be done without all of the volunteers. I was fortunate to have dedicated crew members.
Which of the performers were the most surprising, as in, "WOW I didnt know he or she could sing, play, etc.?
"You cant single out a performance because everyone was fantastic this year. We had more performers this year than ever before and had to limit the number of acts (to 18).
In your own words, what makes the concert so special?
"Everybody who puts in their time and effort did it for IvaDean. We are all doing it for a common purpose: IvaDean. I can come to her with a question, and two minutes later she has the answer. Even though it is her job, she does it so well. She has to deal with all four years worth of work, and its very challenging.
IvaDean Concert 2012
IvaDean Concert 2012
IvaDean Concert 2012
IvaDean Concert 2012
IvaDean Concert 2012
IvaDean Concert 2012
IvaDean Concert 2012
IvaDean Concert 2012
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.